Embody GLP-1 reports an average loss of 1.5% of body weight per week at therapeutic doses, which works out to roughly 10 to 20 pounds over 12 weeks for a 200-pound patient
[ 5 ] Semaglutide shows a similar pattern: Stop the injections, and weight often creeps back up
Ozempic (semaglutide up to 2mg) is approved and commonly prescribed to lower HbA1c and improve blood sugar control in adults with type 2 diabetes, typically alongside diet changes and other medications
Getting started on treatment today is better than waiting 2-3 years for the "perfect" medication
The article names severe upper abdominal pain radiating to the back as a sign of possible acute pancreatitis, along with persistent severe vomiting, vision changes, and signs of hypoglycemia in insulin-treated patients
There are no major side effects to the treatment